Daniel Freedman

Dr. Daniel Freedman

orcid

Research Focus & Metrics

Representative Publications

View All Publications
1 January 2014 in Journal of Photopolymer Science and Technology
Verified
Journal Article
Open access
JPJames Passarelli
James Passarelli
MSMiriam Sortland
Miriam Sortland
RRRyan Del Re
Ryan Del Re
BCBrian Cardineau
Brian Cardineau
CSChandra Sarma
Chandra Sarma
RBRobert L. Brainard
Robert L. Brainard

28 March 2024 in Clinical and Translational Imaging
Verified
Journal Article
Closed access
PDF file
SWSungmin Woo
Sungmin Woo
DFDaniel Freedman
Daniel Freedman
ABAnton S. Becker
Anton S. Becker
DLDoris Leithner
Doris Leithner
Marius MayerhoeferMarius Mayerhoefer
Marius Mayerhoefer
HVHebert A. Vargas
Hebert A. Vargas

4 August 2025 in arXiv
Verified
Preprint
Open access
PDF file
RDRadhika Dua
Radhika Dua
YJYoung Joon
Young Joon
FKFred Kwon
Fred Kwon
SDSiddhant Dogra
Siddhant Dogra
DFDaniel Freedman
Daniel Freedman
EOEric Karl Oermann
Eric Karl Oermann
Radiological imaging is central to diagnosis, treatment planning, and clinical decision-making. Vision-language foundation models have spurred interest in automated radiology report generation (RRG), but safe deployment requires reliable clinical evaluation of generated reports. Existing metrics often rely on surface-level similarity or behave as black boxes, lacking interpretability. We introduce ICARE (Interpretable and Clinically-grounded Agent-based Report Evaluation), an interpretable evaluation framework leveraging large language model agents and dynamic multiple-choice question answering (MCQA). Two agents, each with either the ground-truth or generated report, generate clinically meaningful questions and quiz each other. Agreement on answers captures preservation and consistency of findings, serving as interpretable proxies for clinical precision and recall. By linking scores to question-answer pairs, ICARE enables transparent, and interpretable assessment. Clinician studies show ICARE aligns significantly more with expert judgment than prior metrics. Perturbation analyses confirm sensitivity to clinical content and reproducibility, while model comparisons reveal interpretable error patterns.

18 September 2024 in Abdominal Radiology
Verified
Journal Article
Closed access
PDF file
DFDaniel Freedman
Daniel Freedman
BBBarun Bagga
Barun Bagga
KMKira Melamud
Kira Melamud
TOThomas O’dOnnell
Thomas O’dOnnell
EVEmilio Vega
Emilio Vega
BDBari Dane
Bari Dane

28 October 2026 in CardioVascular and Interventional Radiology
Verified
Journal Article
Closed access
PDF file
DFDaniel Freedman
Daniel Freedman
FBFrederic Bertino
Frederic Bertino

28 October 2026 in Lymphatics
Verified
Journal Article
Open access
PDF file
AVAndre Constantin Vogel
Andre Constantin Vogel
DFDaniel Freedman
Daniel Freedman
PCPatrick Carey
Patrick Carey
ASAbhay Srinivasan
Abhay Srinivasan
MSMikhail Silk
Mikhail Silk
DKDhara Kinariwala
Dhara Kinariwala
Acquired lymphatic flow disorders include chylothorax, plastic bronchitis, chylous ascites, protein-losing enteropathy, and post-operative lymphocele. These heterogenous clinical entities share common mechanisms and pathophysiology: disruption to normal antegrade flow of lymphatic fluid. Advances in imaging and interventional techniques have improved physicians’ ability to diagnose and treat these diseases. Workup with computed tomography, heavily T2-weighted MRI, and dynamic contrast-enhanced magnetic resonance lymphangiography can elucidate etiologies and provide targets for intervention. Initial management consists of very-low fat diets, medium chain triglyceride supplementation, and pharmacologic therapy with somatostatin analogs. If conservative management fails, interventions like thoracic duct embolization, thoracic duct stent-grafting and decompression, transjugular intrahepatic porto-systemic shunting, and lymphatic channel embolization offer novel, minimally invasive options, with surgery reserved for refractory cases. Future investigations will establish long-term outcomes after thoracic duct embolization, elucidate the relative benefit of thoracic duct embolization versus stent-grafting, and establish standardized treatment algorithms for post-operative lymphocele. In this review, we discuss the etiologies, workup, diagnosis, and management of acquired lymphatic flow disorders.